Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Merus (MRUS – Research Report), CureVac (CVAC – Research Report) and Roche Holding AG (RHHVF – Research Report).
Merus (MRUS)
Jefferies analyst Maury Raycroft maintained a Buy rating on Merus yesterday and set a price target of $45.00. The company’s shares closed last Thursday at $24.47.
According to TipRanks.com, Raycroft is a 4-star analyst with an average return of
Merus has an analyst consensus of Strong Buy, with a price target consensus of $46.67.
See today’s best-performing stocks on TipRanks >>
CureVac (CVAC)
In a report released yesterday, Eun Yang from Jefferies maintained a Buy rating on CureVac, with a price target of $21.00. The company’s shares closed last Thursday at $6.50, close to its 52-week low of $5.47.
According to TipRanks.com, Yang is a 4-star analyst with an average return of
Currently, the analyst consensus on CureVac is a Moderate Buy with an average price target of $19.50, representing a 167.5% upside. In a report released yesterday, JMP Securities also reiterated a Buy rating on the stock with a $18.00 price target.
Roche Holding AG (RHHVF)
J.P. Morgan analyst Richard Vosser maintained a Sell rating on Roche Holding AG today and set a price target of CHF260.00. The company’s shares closed last Thursday at $274.44, close to its 52-week low of $268.39.
Vosser has an average return of
According to TipRanks.com, Vosser is ranked #914 out of 8548 analysts.
The word on The Street in general, suggests a Hold analyst consensus rating for Roche Holding AG with a $320.93 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on MRUS:
